Anavar 10

Orals

Anavar 10

Anavar 10 is a pharmaceutical tablet formulation of Oxandrolone at 10 milligrams per tablet. Oxandrolone is a synthetic anabolic steroid first synthesized in 1962 with a uniquely mild androgenic profile. Its modification of the A-ring structure — replacement of the C-2 carbon with an oxygen atom — produces a compound with markedly reduced androgenic activity, negligible estrogenic conversion, and a well-characterized safety profile that has supported its clinical use in a variety of catabolic and wasting conditions.

Structural Profile

Oxandrolone is a 17-alpha methyl, 2-oxa derivative of DHT. The C-2 oxygen substitution in the A-ring significantly reduces binding affinity at androgen receptors in androgenic target tissues (skin, prostate, scalp) while preserving strong anabolic activity in skeletal muscle, producing an anabolic-to-androgenic ratio of approximately 322–630:24 (vs testosterone 100:100). Being a DHT derivative, oxandrolone is completely resistant to aromatization and 5-alpha reduction, making estrogenic side effects essentially absent.

Pharmacokinetic Profile

Oxandrolone is absorbed efficiently from the gastrointestinal tract with approximately 97% oral bioavailability — among the highest of any oral steroid — owing to its relative resistance to hepatic first-pass catabolism. Peak plasma concentrations occur at 1–2 hours post-dose. The plasma elimination half-life is 9–10 hours, allowing for twice-daily dosing. Approximately 28% of the administered dose is excreted unchanged in urine, with the remainder hepatically metabolized to hydroxylated and epimeric derivatives.

Mechanism of Action

Oxandrolone binds the androgen receptor with moderate-to-high affinity, activating androgen-responsive gene networks governing skeletal muscle protein synthesis, nitrogen retention, and IGF-1 expression. The compound has been clinically demonstrated to increase lean body mass, reduce visceral fat, and enhance wound healing in conditions of severe catabolism. Unlike most oral anabolics, oxandrolone shows a relatively benign effect on serum lipid profiles and hepatic enzyme markers at therapeutic doses.

Formulation

Each Anavar 10 tablet contains 10 mg Oxandrolone USP as active ingredient, compounded with pharmaceutical-grade excipients. Manufactured to USP specification under GMP conditions. Release testing includes HPLC concentration verification (specification: 95–105% of label claim), purity analysis (specification: ≥98%), dissolution testing, and microbiological limit testing. A Certificate of Analysis is issued for every production lot.

Quality Assurance

Every batch of Anavar 10 produced by Biomedica undergoes the complete pharmaceutical release testing protocol before distribution. This includes HPLC compound identity confirmation and purity analysis (specification: ≥98%), concentration verification (specification: ±5% of label claim), sterility testing per USP <71>, bacterial endotoxin quantification by LAL assay (specification: <0.25 EU/mL), and particulate matter inspection per USP <788>. A Certificate of Analysis is issued for every production lot.

Authentication

Each unit of Anavar 10 carries a unique authentication code on its outer packaging. This code can be verified instantly on our Authentication page to confirm the product is genuine Biomedica stock.